Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial

Janet L. Kwiatkowski, Mark C. Walters, Suradej Hongeng, Evangelia Yannaki, Andreas E. Kulozik, Joachim B. Kunz, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal,

The Lancet · 2024 · 38 citations · 14 references

Concepts

References

14